Jane Street
PACB icon

Jane Street’s Pacific Biosciences PACB Stock Holding History

Jane Street’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.5K Buy
+50,400
New +$90.2K ﹤0.01% 10854
2025
Q1 		– Sell
-472,500
Closed -$865K – 10303
2024
Q4 		$865K Buy
472,500
+181,500
+62% +$354K ﹤0.01% 5657
2024
Q3 		$495K Sell
291,000
-9,300
-3% -$15.3K ﹤0.01% 7194
2024
Q2 		$411K Buy
300,300
+212,100
+240% +$428K ﹤0.01% 7324
2024
Q1 		$331K Sell
88,200
-37,000
-30% -$217K ﹤0.01% 7402
2023
Q4 		$1.23M Sell
125,200
-8,400
-6% -$68.7K ﹤0.01% 5187
2023
Q3 		$1.12M Buy
133,600
+52,400
+65% +$599K ﹤0.01% 5018
2023
Q2 		$1.08M Sell
81,200
-139,500
-63% -$1.7M ﹤0.01% 5079
2023
Q1 		$2.56M Buy
220,700
+124,400
+129% +$1.24M ﹤0.01% 3416
2022
Q4 		$788K Sell
96,300
-118,900
-55% -$1.02M ﹤0.01% 5372
2022
Q3 		$1.25M Buy
215,200
+102,700
+91% +$589K ﹤0.01% 5019
2022
Q2 		$497K Buy
112,500
+5,400
+5% +$32.8K ﹤0.01% 6754
2022
Q1 		$975K Buy
107,100
+52,000
+94% +$599K ﹤0.01% 6196
2021
Q4 		$1.13M Sell
55,100
-29,300
-35% -$707K ﹤0.01% 5653
2021
Q3 		$2.16M Sell
84,400
-55,000
-39% -$1.63M ﹤0.01% 4329
2021
Q2 		$4.88M Sell
139,400
-24,100
-15% -$701K ﹤0.01% 2681
2021
Q1 		$5.45M Buy
163,500
+45,700
+39% +$1.6M ﹤0.01% 2293
2020
Q4 		$3.06M Buy
+117,800
New +$2M ﹤0.01% 2791

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street's PACB Position: Q1 2026 in Review

Jane Street reduced its Pacific Biosciences (PACB) stake by 7.4% in Q1 2026, selling an estimated $198K and leaving 1,390,070 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #5260.

Jane Street first reported a position in PACB in Q3 2013 and has held it in 31 quarters since. The position peaked at $6.66M in Q1 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Jane Street held 1,390,070 shares of Pacific Biosciences worth $1.83M as of Q1 2026.
  • Jane Street sold 110,448 Pacific Biosciences shares in Q1 2026, an estimated $198K.
  • Pacific Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5260 holding.
  • Jane Street first reported a position in Pacific Biosciences in Q3 2013 and has held it in 31 quarters since.
  • Jane Street's Pacific Biosciences position peaked at $6.66M in Q1 2021.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.